Fidelity Europe Quality Income UCITS ETF EUR Acc (GBP) | FEQDRegistrer dig for at låse op for ratings |
Fondens performance | 31-05-2024 |
Vækst af 1.000 (DKK) | Avanceret graf |
Fond | -3,0 | 24,9 | -15,9 | 18,5 | 6,8 | |
+/-Kat | 4,4 | 4,3 | -7,5 | 4,6 | -1,3 | |
+/-Indeks | 8,3 | 3,8 | -14,0 | 4,2 | -1,8 | |
Kategori: Aktier - Europa Højt Udbytte | ||||||
Kategoribenchmark: Morningstar DM Eur Div Yld ... |
Oversigt | ||
Closing Price 14-06-2024 | GBX 632,75 | |
Kursændring 1 dag | -0,96% | |
Morningstar Kategori™ | Aktier - Europa Højt Udbytte | |
Omsætning | 533 | |
Børs | LONDON STOCK EXCHANGE, THE | |
ISIN | IE00BYSX4283 | |
Markedsværdi i alt (mio.) 14-06-2024 | EUR 35,04 | |
Seneste TNA(mio.) 14-06-2024 | EUR 14,25 | |
Løbende omkostning 24-05-2024 | 0,30% | |
Investeringsstrategi | Passiv |
Investeringsmålsætning: Fidelity Europe Quality Income UCITS ETF EUR Acc (GBP) | FEQD |
The investment objective of the Sub-Fund is to provide investors with a total return, taking into account both capital and income returns, which reflects, before fees and expenses, the return of the Index (or such other index determined by the Directors from time to time as being able to track substantially the same market as the Index). |
Returns | |||||||||||||
|
Management | ||
Manager navn Startdato | ||
Ikke oplyst af foreningen 01-04-2022 | ||
Startdato 30-10-2017 |
Annonce |
Kategoribenchmark | |
Fondens indeks | Morningstar indeks |
Fidelity Europe Quality Income NR EUR | Morningstar DM Eur Div Yld >2.5% NR EUR |
Target Market | ||||||||||||||||||||
|
Formuefordeling Fidelity Europe Quality Income UCITS ETF EUR Acc (GBP) | FEQD | 14-06-2024 |
|
|
Top 5 placeringer | Sektor | % |
Novo Nordisk A/S Class B | Healthcare | 4,67 |
ASML Holding NV | Teknologi | 4,39 |
Nestle SA | Forbrugsvarer | 3,12 |
Lvmh Moet Hennessy Louis Vuitton SE | Cyklisk forbrug | 2,46 |
Novartis AG Registered Shares | Healthcare | 2,43 |
Øget Mindsket Ny siden sidste portefølje | ||
Fidelity Europe Quality Income UCITS ETF EUR Acc (GBP) | FEQD |